Skip to main content
Equibles
TARA logo

TARA · Protara Therapeutics, Inc. · Metrics

Track TARA — free

Use TARA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TARA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.44 -0.18 (-6.87%) At close · Nov 12
Russell 2000 member Rebalance outlook locked
Market Cap
$150.23M
Shares
61.57M
Volume · Nov 12 1.14M Avg daily vol (3M) 1M

TARA metrics

71 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$2.44
Market cap
$150.23M

Price action

23 metrics
Price change (1W)
+11.5%
Price change (30D)
+0.0%
Price change (3M)
-32.6%
Price change (6M)
-49.6%
Price change (YTD)
-50.8%
Price change (1Y)
-51.1%
Trailing year
Price change (5Y)
-64.5%
52-week high
$7.56
52-week low
$2.13
Change from 52-week high
-65.3%
Change from 52-week low
+23.0%
Annualized volatility
72.6%
Annualized volatility (3M)
58.8%
Implied volatility (30D)
104.7%
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
1.1
RSI (14D)
51.6
Price vs SMA 50
-11.2%
Price vs SMA 200
-40.8%
Avg volume (3M)
992,644
Relative volume
0.8
Average dollar volume
$2.99M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
61.57M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
1.1
reciprocal yield 87.4%
FCF yield
—
TTM · current market cap
Buyback yield
0.1%
P / FCF
—
P / operating cash flow
—
Earnings yield
-48.6%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.1%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-05-26

Profitability

9 metrics
Gross margin
—
Operating margin
-257.1%
Trailing 12 months
Net margin
-113.4%
Gross profit (TTM)
—
Operating profit (TTM)
−$85.19M
Net income (TTM)
−$78.44M
Trailing 12 months
Diluted EPS (TTM)
$-1.41
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$-1.51
EBITDA per diluted share (TTM)
$-73.63
Net income per diluted share (TTM)
$-1.39
Operating cash flow per diluted share (TTM)
$-1.28
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
$1.07
Stock compensation per diluted share (TTM)
$0.09
Book value per share
$3.67

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+48.7%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-55.6%
Return on assets
-50.1%
Debt / equity
0.0
Current ratio
9.0
EBITDA (TTM)
−$31.49M
Free cash flow (TTM)
—
Quick ratio
9.0
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$127.05M
Latest balance sheet
Cash & equivalents
$25.15M
Total assets
$156.54M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$72.12M
Capital expenditures (TTM)
$1.08M
R&D (TTM)
$60.45M
SG&A (TTM)
—
Stock compensation (TTM)
$5.38M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
119
13F filer change QoQ
+5
Institutional ownership
74.9%
Conviction holders (share of 13F filers)
0.8%
Crowding (high-turnover and private-fund holders)
41.1%
Private-fund adviser ownership
36.7%
Active holders' share change QoQ
-1.4%
Holder tenure
7.5
Price vs estimated holder cost
-20.6%

Ownership (registered funds)

1 metrics
Index-fund ownership
10.2%

Short interest

3 metrics
Short interest
5.3%
Latest settlement · 2.9 days to cover
Days to cover
2.9d
Short-squeeze score
37 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1359931 CUSIP 74365U107 13F (30d) 53 filings 50 filers Visit website Investor relations